Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Charbonnier

Showing results (1-10 of 108) with videos related to

Pageof 11
Sort By:
Archives Des Maladies Du Coeur Et Des Vaisseaux|March 7, 1998
[Fraxiparin and prevention of left ventricular thrombosis in non-thrombolyzed myocardial infarction. FRATIV Study]B Charbonnier
La Revue Du Praticien|December 3, 1999
[Indications for thrombolytics]B Charbonnier
Archives Des Maladies Du Coeur Et Des Vaisseaux|May 1, 1992
[Thrombolytic treatment during the acute phase of myocardial infarction. An important reduction of early and secondary mortality]B Charbonnier
La Revue Du Praticien|March 25, 2000
[Major pulmonary embolism]B Charbonnier
Archives Des Maladies Du Coeur Et Des Vaisseaux|January 25, 2002
[Fibrinolytics in venous thromboembolic disease]B Charbonnier, G Pacouret
Optics Letters|October 31, 2009
Continuum generated by chromatic dispersion and power variations in periodically amplified soliton linksT Georges, B Charbonnier
Archives Des Maladies Du Coeur Et Des Vaisseaux|February 1, 1990
[Effects of anistreplase on coronary patency in acute myocardial infarction]G Pacouret, B Charbonnier
Presse Medicale (Paris, France : 1983)|December 10, 1994
[Role of low molecular weight heparins for treating non-massive pulmonary embolism]B Charbonnier, G Pacouret
Archives Des Maladies Du Coeur Et Des Vaisseaux|November 1, 1987
[New thrombolytic agents in myocardial infarction]B Charbonnier, M Lang, M Brochier
Annales De Cardiologie Et D'Angeiologie|May 1, 1993
[A new cause of torsades de pointes: combination of terfenadine and troleandomycin]P Fournier, G Pacouret, B Charbonnier
Pageof 11

Showing results (1-10 of 108) with videos related to

Sort By:
Pageof 11
Archives Des Maladies Du Coeur Et Des Vaisseaux|March 7, 1998
[Fraxiparin and prevention of left ventricular thrombosis in non-thrombolyzed myocardial infarction. FRATIV Study]B Charbonnier
La Revue Du Praticien|December 3, 1999
[Indications for thrombolytics]B Charbonnier
Archives Des Maladies Du Coeur Et Des Vaisseaux|May 1, 1992
[Thrombolytic treatment during the acute phase of myocardial infarction. An important reduction of early and secondary mortality]B Charbonnier
La Revue Du Praticien|March 25, 2000
[Major pulmonary embolism]B Charbonnier
Archives Des Maladies Du Coeur Et Des Vaisseaux|January 25, 2002
[Fibrinolytics in venous thromboembolic disease]B Charbonnier, G Pacouret
Optics Letters|October 31, 2009
Continuum generated by chromatic dispersion and power variations in periodically amplified soliton linksT Georges, B Charbonnier
Archives Des Maladies Du Coeur Et Des Vaisseaux|February 1, 1990
[Effects of anistreplase on coronary patency in acute myocardial infarction]G Pacouret, B Charbonnier
Presse Medicale (Paris, France : 1983)|December 10, 1994
[Role of low molecular weight heparins for treating non-massive pulmonary embolism]B Charbonnier, G Pacouret
Archives Des Maladies Du Coeur Et Des Vaisseaux|November 1, 1987
[New thrombolytic agents in myocardial infarction]B Charbonnier, M Lang, M Brochier
Annales De Cardiologie Et D'Angeiologie|May 1, 1993
[A new cause of torsades de pointes: combination of terfenadine and troleandomycin]P Fournier, G Pacouret, B Charbonnier
Pageof 11